Nexteer Reports Strong First-Half 2025 Results
Driven by Growth with China OEMs, Technology Leadership & Strategic Expansion …
Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
Announced first patient dosed in the Phase 2b placebo-controlled portion of the…
Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results
Posts Positive Organic Growth and Adjusted EBITDA1 of 23.5% of Revenue CINCINNATI,…
Lexin Reports Q2 2025 Financial Results: Revenue Hits RMB 3.59B with 15.6% QoQ Growth; Profit Rises for 5 Straight Quarters as Scenario-Based Transactions Surge to Spur Consumption
Shenzhen, China , Aug. 08, 2025 (GLOBE NEWSWIRE) -- On August 7,…
Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update
– LOQTORZI net revenue was $10.0 million, a 36% increase over Q1…
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 06, 2025 16:45 ET | Source: Neuronetics MALVERN, Pa., Aug. 06,…
Gilat Reports Second Quarter 2025 Results
Revenues Increased by 37%; GAAP Operating Income of $5.7 Million; Adjusted EBITDA…
Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update
Recorded second quarter 2025 worldwide revenue of $378.0 million, GAAP fully diluted…
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025 16:15 ET | Source: ImageneBio, Inc. SAN DIEGO, Aug.…
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025 16:08 ET | Source: Protara Therapeutics NEW YORK, Aug.…
